Twin Securities Inc. Purchases New Position in Amedisys, Inc. (NASDAQ:AMED)

Twin Securities Inc. acquired a new position in shares of Amedisys, Inc. (NASDAQ:AMED) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,945 shares of the health services provider’s stock, valued at approximately $1,153,000. Amedisys comprises about 1.3% of Twin Securities Inc.’s holdings, making the stock its 10th biggest holding.

Other large investors have also recently added to or reduced their stakes in the company. Arizona State Retirement System increased its stake in shares of Amedisys by 2.0% in the second quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider’s stock valued at $840,000 after buying an additional 177 shares in the last quarter. Signaturefd LLC increased its position in Amedisys by 20.9% in the 3rd quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock valued at $132,000 after acquiring an additional 236 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Amedisys by 0.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 31,199 shares of the health services provider’s stock worth $2,876,000 after acquiring an additional 255 shares during the last quarter. State of Alaska Department of Revenue lifted its position in shares of Amedisys by 7.2% during the third quarter. State of Alaska Department of Revenue now owns 3,782 shares of the health services provider’s stock worth $365,000 after purchasing an additional 255 shares in the last quarter. Finally, CWM LLC grew its stake in shares of Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock valued at $211,000 after purchasing an additional 277 shares during the last quarter. 94.36% of the stock is owned by institutional investors.

Amedisys Stock Performance

Shares of Amedisys stock opened at $91.41 on Friday. The firm has a 50 day simple moving average of $94.86 and a 200 day simple moving average of $95.64. Amedisys, Inc. has a fifty-two week low of $88.81 and a fifty-two week high of $98.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The firm has a market cap of $2.99 billion, a P/E ratio of 36.27, a P/E/G ratio of 1.92 and a beta of 0.78.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same period last year, the business posted $0.98 earnings per share. The firm’s quarterly revenue was up 5.7% on a year-over-year basis. Sell-side analysts predict that Amedisys, Inc. will post 4.55 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.